Samaritan Pharmaceuticals, Inc.: Early Stage Alzheimer's Disease Diagnostic Patent Issued in Australia

LAS VEGAS, May 29, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that the Australian patent application No. 31142/01, Title: Neurosteroids as Markers for Alzheimer's disease, has been issued.

Back to news